NeuroOne targets at least $10.5M revenue in 2026 while advancing brain and pain therapy platforms
Source: SeekingAlpha
2026-02-17 10:25:51 ET
More on NeuroOne Medical Technologies
- NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
- NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript
- NeuroOne plans 2026 drug delivery commercialization as Q4 product revenue jumps 907%
- Seeking Alpha’s Quant Rating on NeuroOne Medical Technologies
- Historical earnings data for NeuroOne Medical Technologies
Read the full article on Seeking Alpha
For further details see:
NeuroOne targets at least $10.5M revenue in 2026 while advancing brain and pain therapy platforms
NeuroOne Medical Technologies Corporation
NASDAQ: NMTC
NMTC Trading
-6.47% G/L:
$0.795 Last:
336,870 Volume:
$0.82 Open:
NMTC Latest News
March 05, 2026 09:00:00 am
Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments
March 03, 2026 08:34:43 am
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
February 26, 2026 08:34:44 am
NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time
NMTC Stock Data
$42,347,044
45,926,378
0.01%
16
N/A
Medical Equipment & Supplies
Healthcare
US
Eden Prairie
